In our current study, we used genetic editing in the zebrafish to define the in vivo mechanism underlying the striking association between the germline rs2168101 G → T noncoding polymorphism in the first intron of lmo1 and the risk of developing neuroblastoma. The gene discussed is LMO1; the disease is neuroblastoma.